USPTO serial 85599026
XALUPRINE
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- HETZEL, DANNEAN
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with XALUPRINE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Richard M. Goldberg
RICHARD M. GOLDBERG RICHARD M. GOLDBERG25 E SALEM ST STE 419HACKENSACK, NJ 07601-7416UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical compositions and preparations for the treatment of leukemia; vaccines for human use; compositions for medicinal use for the treatment of leukemia; compositions for medicinal use comprising any biological and/or pharmaceutical ingredient for the treatment of leukemia; sanitary preparations for medical purposes; syringes sold filled with mercaptopurine; injectors and delivery devices for medical purposes containing mercaptopurine; parts and fittings for all the aforesaid goods | ACTIVE | — |
| 010 | Apparatus for use in the delivery of pharmaceutical materials and drugs, namely, injection needles; syringes and injectors for medical purposes; surgical and medical apparatus and instruments, parts and fittings for all the aforesaid goods | ACTIVE | — |
| 042 | Scientific and technological services, namely, scientific research, testing, process and formulation development, engineering support services, laboratory services, all in the field of pharmaceutical, microbiological and medical industries; industrial analysis and research services in the field of pharmaceuticals; information, advisory and consultancy services in relation to all the aforesaid services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Nova Bio-Pharma Technologies Limited
- Other trademarks owned by Nova Bio-Pharma Technologies Limited
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named XALUPRINE
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 8, 2014 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 8, 2014 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 8, 2014 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 7, 2014 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jan 28, 2014 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jan 28, 2014 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 20, 2013 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 19, 2013 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 15, 2013 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jul 17, 2013 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 17, 2013 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 5, 2013 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 11, 2012 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 11, 2012 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 21, 2012 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 7, 2012 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 4, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 3, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 3, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 30, 2012 | ALIE | ASSIGNED TO LIE | — |
| Oct 17, 2012 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 2, 2012 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 2, 2012 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 2, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 31, 2012 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 23, 2012 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 19, 2012 | NWAP | NEW APPLICATION ENTERED | — |